Adverse Outcome Pathway-Driven Analysis of Liver Steatosis <i>in Vitro</i>: A Case Study with Cyproconazole
Claudia Luckert(Federal Institute for Risk Assessment), Alfonso Lampen(Federal Institute for Risk Assessment), Efrosini S. Katsanou(Benaki Phytopathological Institute), Marianna Stamou(AstraZeneca (Sweden)), Anastasia Spyropoulou(Benaki Phytopathological Institute), Deborah Rijkers(Wageningen University & Research), Shana J. Sturla(ETH Zurich), Bernd Wollscheid(University of Zurich), Roger Rahmani(Centre National de la Recherche Scientifique), Emanuela S. Milani(Board of the Swiss Federal Institutes of Technology), Geert Stoopen(Wageningen University & Research), Sigrid Durinck(Ghent University), Kyriaki Machera(Benaki Phytopathological Institute), Andreja Rajković(Ghent University), Albert Braeuning(Federal Institute for Risk Assessment), Georges de Sousa, Παρθένα Κωνσταντινίδου(Benaki Phytopathological Institute), Nathalie Zucchini-Pascal(Toxicologie Alimentaire), Ad Peijnenburg(Wageningen University & Research)
Cited by 77
Related Papers
Distribution, Elimination, and Toxicity of Silver Nanoparticles and Silver Ions in Rats after 28-Day Oral Exposure
|ACS Nano|2012|708
Guidance on the use of the Threshold of Toxicological Concern approach in food safety assessment
|EFSA Journal|2019|341
Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: human and animal health
|EFSA Journal|2021|336